Affiliation: Johnson and Johnson Pharmaceutical Research and Development
- Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomesDanielle Coppola
Benefit Risk Management, a division of Johnson and Johnson Pharmaceutical Research and Development, LLC, Titusville, New Jersey 08560, USA
Drug Saf 30:247-64. 2007..A significant number of women of childbearing age have schizophrenia or other psychoses. This means that there is a considerable risk of in utero exposure to risperidone due to maternal use...